ISB News

Dr. Lee Hood Writes ‘Second Opinion’ Columns for Los Angeles Times

ISB Co-founder, Chief Strategy Officer and Professor Dr. Lee Hood is credited with coining the term “systems biology,” and has been a longtime advocate of P4 medicine (predictive, preventive, personalized and participatory).

Now, Hood has been selected by the Los Angeles Times to share his insights in a new weekly op-ed column, called Second Opinion.

The column “aims to engage cutting-edge debates about the unprecedented global challenges that our society faces” and “will feature contributions from thought leaders, scientists, diplomats, humanitarians, artists, economists, and other experts who will offer their insights into these challenges, in an effort to identify solutions and actions to solve them,” said Dr. Patrick Soon-Shiong, executive chairman of the L.A. Times, in an article announcing the weekly column.

Hood has penned two columns, and more are in the works. The Second Opinion columns are published in print in Sunday Los Angeles Times newspapers and appear on latimes.com. They are also syndicated by Yahoo News and many other outlets. Prior to the launch of Second Opinion, Hood and author Matthew LaPlante wrote an op-ed for the Los Angeles Times.

Dr. Hood’s Columns:

 

Claire Reid / Los Angeles Times; Getty Images, Unsplash

Image Courtesy Claire Reid / Los Angeles Times; Getty Images, Unsplash

Op-Ed: The key to treating Alzheimer’s disease may not be a drug
June 30, 2021

Read more

Los Angeles Times Image

Image courtesy Los Angeles Times / Nicole Vas

Second Opinion: How long haul COVID could offer clues for treating other puzzling illnesses
April 18, 2021

Read more

Los Angeles Times Image

Image courtesy Los Angeles Times / Science Photo Library / Associated Press

Second Opinion: Getting past disease to the science of wellness
March 21, 2021

Read more

Los Angeles Times Image

Image courtesy Los Angeles Times / Associated Press

Op-Ed: How science education can stave off demagogues
January 24, 2021

Read more

Recent Articles

  • Spotlight on ISB Education graphic

    2023-24 School Year ISB Education Highlights

    Each month throughout the 2023-2024 academic year, we will highlight some of the top projects the ISB Education team is working on.

  • Breakthrough T Cell Discovery Has Huge Potential for Engineering Custom Immune Responses

    In a breakthrough discovery that changes how we understand T cells and with implications of how we can better engineer custom immune responses to fight disease, Institute for Systems Biology researchers showed that the different disease-fighting functions of different T cells are determined by the genetically encoded T-cell receptor sequence that are unique to those cells.

  • ISB Researchers Find a Chink in the Armor of Tuberculosis Pathogen

    By using a computer model to understand the adaptions of Mycobacterium tuberculosis (Mtb), the pathogen that causes tuberculosis, researchers at ISB have identified a network within Mtb that allows it to tolerate and resist drug therapies. This work is published in Cell Reports.